ag-1296 has been researched along with Innate Inflammatory Response in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, M | 1 |
| Zhou, C | 1 |
| Ji, L | 1 |
| Pan, B | 1 |
| Zheng, L | 1 |
1 other study available for ag-1296 and Innate Inflammatory Response
| Article | Year |
|---|---|
AG1296 enhances plaque stability via inhibiting inflammatory responses and decreasing MMP-2 and MMP-9 expression in ApoE-/- mice.
Topics: Animals; Apolipoproteins E; Down-Regulation; Inflammation; Matrix Metalloproteinase 2; Matrix Metall | 2017 |